10X GENOMICS XENIUM PRIME REAGENTS
SAM.GOV Due: May 23, 2025 at 02:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The opportunity for 10X Genomics Xenium Prime Reagents is a combined synopsis/solicitation issued by the National Institutes of Health (NIH) under the National Institute of Allergy and Infectious Diseases (NIAID). This procurement is aimed at acquiring specific reagents necessary for spatial transcriptomics research involving induced pluripotent stem cells (iPSCs) and human brain tissue related to multiple sclerosis (MS). The selected contractor will be responsible for providing brand name supplies, including various Xenium Prime assay kits and related products, which are critical for ongoing research projects. Businesses with expertise in biological product manufacturing and those capable of delivering high-resolution imaging-based spatial profiling technology should consider bidding on this opportunity, as it requires a firm fixed price purchase order based on technical capability, price, and delivery timelines.
Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commerci

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325414
Set Aside
None
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
RITA DAVIS [email protected] 3017617461 primary
Attachments
  • Award_Terms_and_Conditions_FAR_52.212-5.pdf